SMTI vs. BVS
SMTI (Sanara MedTech Inc.) and BVS (Bioventus Inc.) are both stocks. Both are in the Healthcare sector — SMTI in Medical Instruments & Supplies, BVS in Medical Devices. Over the past 5 years, SMTI returned -9.64%/yr vs -12.44%/yr for BVS. At a 0.21 correlation, their price movements are largely independent.
Performance
SMTI vs. BVS - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, SMTI achieves a -6.85% return, which is significantly lower than BVS's 24.87% return.
SMTI
- 1D
- 0.00%
- 1M
- -6.13%
- YTD
- -6.85%
- 6M
- -11.26%
- 1Y
- -21.82%
- 3Y*
- -18.72%
- 5Y*
- -9.64%
- 10Y*
- 14.13%
BVS
- 1D
- 5.69%
- 1M
- 0.11%
- YTD
- 24.87%
- 6M
- 23.37%
- 1Y
- 42.48%
- 3Y*
- 45.92%
- 5Y*
- -12.44%
- 10Y*
- —
SMTI vs. BVS - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
SMTI Sanara MedTech Inc. | -6.85% | -29.67% | -19.22% | -9.67% | 53.98% | -24.23% |
BVS Bioventus Inc. | 24.87% | -29.14% | 99.24% | 101.92% | -81.99% | -4.04% |
Correlation
The correlation between SMTI and BVS is 0.43, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.43 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.30 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.22 |
Correlation (All Time) Calculated using the full available price history since Feb 11, 2021 | 0.21 |
Over the past year, SMTI and BVS have become more correlated (0.43) than their long-term average of 0.21, meaning their price movements have been converging.
Fundamentals
SMTI:
$195.44M
BVS:
$650.38M
SMTI:
-$3.82
BVS:
$0.41
SMTI:
1.78
BVS:
1.11
SMTI:
27.81
BVS:
3.44
SMTI:
$107.48M
BVS:
$576.30M
SMTI:
$97.21M
BVS:
$390.14M
SMTI:
$16.13M
BVS:
$98.72M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
SMTI vs. BVS — Risk / Return Rank
SMTI
BVS
SMTI vs. BVS - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Sanara MedTech Inc. (SMTI) and Bioventus Inc. (BVS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| SMTI | BVS | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.19 | ||
| Sortino ratioReturn per unit of downside risk | -1.65 | ||
| Omega ratioGain probability vs. loss probability | 0.99 | 1.19 | -0.20 |
| Calmar ratioReturn relative to maximum drawdown | -0.40 | 1.55 | -1.95 |
| Martin ratioReturn relative to average drawdown | -0.65 | 4.92 | -5.58 |
Loading charts...
Drawdowns
SMTI vs. BVS - Drawdown Comparison
The maximum SMTI drawdown since its inception was -97.48%, roughly equal to the maximum BVS drawdown of -95.18%. Use the drawdown chart below to compare losses from any high point for SMTI and BVS.
Loading charts...
Drawdown Indicators
| SMTI | BVS | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -97.48% | -95.18% | -2.30% |
Max Drawdown (1Y)Largest decline over 1 year | -54.29% | -27.51% | -26.78% |
Max Drawdown (3Y)Largest decline over 3 years | -64.47% | -55.22% | -9.25% |
Max Drawdown (5Y)Largest decline over 5 years | -67.11% | -95.07% | +27.96% |
Max Drawdown (10Y)Largest decline over 10 years | -81.82% | — | — |
Current DrawdownCurrent decline from peak | -72.64% | -51.64% | -21.00% |
Average DrawdownAverage peak-to-trough decline | -75.21% | -56.32% | -18.89% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 33.50% | 8.65% | +24.85% |
Volatility
SMTI vs. BVS - Volatility Comparison
Sanara MedTech Inc. (SMTI) has a higher volatility of 16.20% compared to Bioventus Inc. (BVS) at 14.78%. This indicates that SMTI's price experiences larger fluctuations and is considered to be riskier than BVS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| SMTI | BVS | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 16.20% | 14.78% | +1.42% |
Volatility (6M)Calculated over the trailing 6-month period | 39.66% | 33.00% | +6.66% |
Volatility (1Y)Calculated over the trailing 1-year period | 62.46% | 50.96% | +11.50% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 56.42% | 81.09% | -24.67% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 111.45% | 80.64% | +30.81% |
Dividends
SMTI vs. BVS - Dividend Comparison
Neither SMTI nor BVS has paid dividends to shareholders.
Financials
SMTI vs. BVS - Financials Comparison
This section allows you to compare key financial metrics between Sanara MedTech Inc. and Bioventus Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
SMTI vs. BVS - Profitability Comparison
SMTI - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Sanara MedTech Inc. reported a gross profit of 25.87M and revenue of 27.80M. Therefore, the gross margin over that period was 93.1%.
BVS - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Bioventus Inc. reported a gross profit of 90.77M and revenue of 132.09M. Therefore, the gross margin over that period was 68.7%.
SMTI - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Sanara MedTech Inc. reported an operating income of 2.65M and revenue of 27.80M, resulting in an operating margin of 9.5%.
BVS - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Bioventus Inc. reported an operating income of 8.42M and revenue of 132.09M, resulting in an operating margin of 6.4%.
SMTI - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Sanara MedTech Inc. reported a net income of 458.96K and revenue of 27.80M, resulting in a net margin of 1.7%.
BVS - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Bioventus Inc. reported a net income of 3.11M and revenue of 132.09M, resulting in a net margin of 2.4%.
Frequently Asked Questions
SMTI and BVS have a correlation of 0.43, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
SMTI has higher volatility (16.20%) compared to BVS (14.78%). In terms of maximum drawdown, SMTI dropped -97.48% vs BVS's -95.18%.
BVS currently has the higher Sharpe Ratio (0.84 vs -0.35), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for SMTI and BVS
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer